Beijing News Shell Financial News (Reporter Yan Xia) On January 31, the share price of Aonong Biotech opened to the limit, and as of the reporter's finalization, its current stock price is 447 yuan shares, a one-day decline of 1006%, the company's total market capitalization is about 38900 million yuan.
On the news side, Aonong Biotech issued a risk warning announcement on the evening of January 30 on the company's possible delisting risk warning. Regarding the reasons for the possible implementation of the delisting risk warning, Aonong Biotech explained that according to the relevant regulations, "the audited net assets at the end of the most recent fiscal year are negative, or the net assets at the end of the most recent fiscal year after retrospective restatement are negative", according to the calculation of the financial department, Aonong Biotech expects the net assets at the end of the period in 2023 to be negative, so the company may be subject to a delisting risk warning by the Shanghai ** Exchange.
On the other hand, as of January 23, 2024, the total principal and interest of overdue debts accumulated by Aonong Biotech in banks, financial leasing companies and other financial institutions was about 143835$220,000 (net of repaid). From November 2022 to January 30, 2024, the cumulative amount of litigation (arbitration) of Aonong Biotech is 194912800,000 yuan. As of January 8, 2024, the controlling shareholder of Aonong Biotech, Zhangzhou Aonong Investment***, formerly known as "Xiamen Aonong Investment*** referred to as "Aonong Investment") and its concerted actors, have pledged a total of 384526106 shares of Aonong Biotech, accounting for 97 of the company's total shares55%。As of January 25, 2024, the total number of shares frozen and judicially marked by Aonong Investment and its persons acting in concert is 355896261 shares, accounting for 90 of its total shares29%。
Aonong Biotech said: "Considering the above-mentioned matters such as the judicial freezing and judicial marking of some shares of Aonong Investment and Wu Youlin, the actual controller, the subsequent situation of the company's shares held by Aonong Investment and Wu Youlin may face more changes and greater uncertainty, and relevant changes may lead to the risk of instability of control of the company." ”
Proofread by Diyan Chen.